Silva Pharmaceuticals Limited (DSE:SILVAPHL)

Silva Pharmaceuticals Revenue

Silva Pharmaceuticals had revenue of 86.41M BDT in the quarter ending September 30, 2025, a decrease of -12.81%. This brings the company's revenue in the last twelve months to 370.96M, down -32.19% year-over-year. In the fiscal year ending June 30, 2025, Silva Pharmaceuticals had annual revenue of 383.65M, down -36.02%.

• Revenue (ttm): 370.96M
• Revenue Growth: -32.19%
• P/S Ratio: 3.64
• Revenue / Employee: 538.40K
• Employees: 689
• Market Cap: 1.35B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	383.65M	-216.01M	-36.02%
Jun 30, 2024	599.66M	-117.21M	-16.35%
Jun 30, 2023	716.87M	-61.80M	-7.94%
Jun 30, 2022	778.67M	-20.58M	-2.57%
Jun 30, 2021	799.25M	35.91M	4.70%